JP2006514952A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514952A5
JP2006514952A5 JP2004561083A JP2004561083A JP2006514952A5 JP 2006514952 A5 JP2006514952 A5 JP 2006514952A5 JP 2004561083 A JP2004561083 A JP 2004561083A JP 2004561083 A JP2004561083 A JP 2004561083A JP 2006514952 A5 JP2006514952 A5 JP 2006514952A5
Authority
JP
Japan
Prior art keywords
disorder
treatment
disorders
panic
social
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004561083A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514952A (ja
JP4658613B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2003/000902 external-priority patent/WO2004056791A1/en
Publication of JP2006514952A publication Critical patent/JP2006514952A/ja
Publication of JP2006514952A5 publication Critical patent/JP2006514952A5/ja
Application granted granted Critical
Publication of JP4658613B2 publication Critical patent/JP4658613B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004561083A 2002-12-23 2003-12-18 臭化水素酸エスシタロプラム(escitalopramhydrobromide)およびその製造方法 Expired - Lifetime JP4658613B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202005 2002-12-23
PCT/DK2003/000902 WO2004056791A1 (en) 2002-12-23 2003-12-18 Escitalopram hydrobromide and a method for the preparation thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010235287A Division JP2011037893A (ja) 2002-12-23 2010-10-20 臭化水素酸エスシタロプラム(escitalopramhydrobromide)およびその製造方法

Publications (3)

Publication Number Publication Date
JP2006514952A JP2006514952A (ja) 2006-05-18
JP2006514952A5 true JP2006514952A5 (cg-RX-API-DMAC7.html) 2007-01-18
JP4658613B2 JP4658613B2 (ja) 2011-03-23

Family

ID=32668635

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004561083A Expired - Lifetime JP4658613B2 (ja) 2002-12-23 2003-12-18 臭化水素酸エスシタロプラム(escitalopramhydrobromide)およびその製造方法
JP2010235287A Withdrawn JP2011037893A (ja) 2002-12-23 2010-10-20 臭化水素酸エスシタロプラム(escitalopramhydrobromide)およびその製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010235287A Withdrawn JP2011037893A (ja) 2002-12-23 2010-10-20 臭化水素酸エスシタロプラム(escitalopramhydrobromide)およびその製造方法

Country Status (32)

Country Link
US (1) US20040167209A1 (cg-RX-API-DMAC7.html)
EP (1) EP1578738B1 (cg-RX-API-DMAC7.html)
JP (2) JP4658613B2 (cg-RX-API-DMAC7.html)
KR (1) KR20050086933A (cg-RX-API-DMAC7.html)
CN (1) CN100349885C (cg-RX-API-DMAC7.html)
AR (1) AR042652A1 (cg-RX-API-DMAC7.html)
AT (1) ATE388947T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003287919B2 (cg-RX-API-DMAC7.html)
BR (1) BR0317623A (cg-RX-API-DMAC7.html)
CA (1) CA2511142A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107451T1 (cg-RX-API-DMAC7.html)
DE (1) DE60319739T2 (cg-RX-API-DMAC7.html)
DK (1) DK1578738T3 (cg-RX-API-DMAC7.html)
EA (1) EA013116B1 (cg-RX-API-DMAC7.html)
EG (1) EG24729A (cg-RX-API-DMAC7.html)
ES (1) ES2298595T3 (cg-RX-API-DMAC7.html)
IL (1) IL169125A0 (cg-RX-API-DMAC7.html)
IS (1) IS2654B (cg-RX-API-DMAC7.html)
ME (1) MEP5808A (cg-RX-API-DMAC7.html)
MX (1) MXPA05005772A (cg-RX-API-DMAC7.html)
MY (1) MY135468A (cg-RX-API-DMAC7.html)
NO (1) NO20053595L (cg-RX-API-DMAC7.html)
NZ (1) NZ540281A (cg-RX-API-DMAC7.html)
PE (1) PE20040924A1 (cg-RX-API-DMAC7.html)
PL (1) PL378275A1 (cg-RX-API-DMAC7.html)
PT (1) PT1578738E (cg-RX-API-DMAC7.html)
RS (1) RS51092B (cg-RX-API-DMAC7.html)
TW (1) TW200501943A (cg-RX-API-DMAC7.html)
UA (1) UA80170C2 (cg-RX-API-DMAC7.html)
UY (1) UY28148A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004056791A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200504109B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
NZ540281A (en) * 2002-12-23 2008-07-31 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof
NZ549100A (en) * 2004-03-05 2010-02-26 Lundbeck & Co As H Crystalline composition containing escitalopram oxalate
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
KR20080080094A (ko) * 2005-10-14 2008-09-02 하. 룬트벡 아크티에 셀스카브 에스시탈로프람 및 부프로피온의 저용량 조합물을 이용한중추신경계 장애의 치료 방법
AU2006304889A1 (en) * 2005-10-14 2007-04-26 H. Lundbeck A/S Stable pharmaceutical formulations containing escitalopram and bupropion
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
EP2042499B1 (en) * 2006-07-11 2018-06-27 Mitsubishi Tanabe Pharma Corporation Salt of a morpholine compound
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FR3006594A1 (fr) * 2013-06-11 2014-12-12 Sorin Crm Sas Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) * 2017-06-05 2022-12-06 上海奥博生物医药股份有限公司 一种艾司西酞普兰双羟萘酸盐新的制备方法
AU2018349284B2 (en) * 2017-10-09 2023-11-16 428 Pharma BV. New salt and solid state forms of escitalopram
US20240100012A1 (en) 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34712A (en) * 1862-03-18 James h
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
WO2000023431A1 (en) * 1998-10-20 2000-04-27 H. Lundbeck A/S Method for the preparation of citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
HK1043129B (zh) * 1999-10-25 2004-10-21 H‧隆德贝克有限公司 西酞普蘭的製備方法
JP2002020379A (ja) * 2000-05-02 2002-01-23 Sumika Fine Chemicals Co Ltd シタロプラム臭化水素酸塩の結晶およびその結晶化方法
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
ES2223959T3 (es) * 2000-12-04 2005-03-01 Westfalia Separator Ag Procedimiento de pretratamiento de aceites en bruto y grasas en bruto para la produccion de esteres de acidos grasos.
CA2445843A1 (en) * 2001-05-01 2002-11-07 H. Lundbeck A/S The use of enantiomeric pure escitalopram
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
NZ540281A (en) * 2002-12-23 2008-07-31 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof
US20050174782A1 (en) * 2003-03-25 2005-08-11 Chapman Leonard T. Flashlight

Similar Documents

Publication Publication Date Title
MEP5908A (xx) Upotreba enantiomerno čistog escitaloprama
NO20100333L (no) Behandling av nevrotiske forstyrrelser
JP2003531157A5 (cg-RX-API-DMAC7.html)
JP2007513052A5 (cg-RX-API-DMAC7.html)
WO2002085896A8 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
CA2490638A1 (en) Combination therapy wherein a serotonin reuptake inhibitor is used
JP2005538045A5 (cg-RX-API-DMAC7.html)
SI1392697T1 (en) Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f)quinoline
JP2005536339A5 (cg-RX-API-DMAC7.html)
BR0209343A (pt) Antidepressivos de azaheterociclilmetila derivados de [1,4]-benzodioxanos oxaheterociclo-fundidos; métodos de tratamento usando tais compostos; processo para prepará-los
WO2005056056A3 (en) The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
DK1381614T3 (da) Antidepressive azaheterocyclylmethylderivater af 2,3-dihydro-1,4-dioxino[2,3-f]quinoxalin
DK1392700T3 (da) Antidepressive azaheterocyclylmethylderivater af 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalen
JP2007505156A5 (cg-RX-API-DMAC7.html)
BRPI0413587A (pt) usos de um composto e de um inibidor de glyt-1, composição farmacêutica, kit, e, método para o tratamento de doença
NO20052308D0 (no) Nye benzoksazociner og deres terapeutiske anvendelse.
BR0314513A (pt) Derivados de indolealquil antidepressivo de benzodioxano metilaminas fundidos por heterociclo
PT1546151E (pt) Derivados de heterociclicos fundidos com benzodioxanos cicloalquilamina anti-depressivos
WO2002088136A3 (en) Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
ATE283694T1 (de) Neue arzneimittelkombinationen aus reboxetin und pindolol
JP2007513896A5 (cg-RX-API-DMAC7.html)
BR0314431A (pt) Derivados de piperidina antidepressiva dos benzodioxanos fundidos por heterocilo
AR048134A1 (es) La combinacion de un inhibidor de la recaptacion de serotonina y un antagonista del receptor de la histamina 3, el agonista inverso o el agonista parcial
NO20061705L (no) Anvendelse av agomelatin for a fremstille medikamenter tiltenkt for behandlingen av bipolare lidelser
TH68743A (th) เอสซิทาโลแพรม ไฮโดรโบรไมด์และวิธีการเตรียมสารนี้